Lymphadenopathy diagnostic criteria: Difference between revisions
Farima Kahe (talk | contribs) No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}};{{AE}}{{ADS}}{{DYM}} | {{CMG}};{{AE}}{{ADS}}{{DYM}} | ||
==Overview== | ==Overview== | ||
Diagnostic criteria for malignant [[lymphadenopathy]] may include: the size of [[node]] more than 2 cm, a node that is draining, hard, or fixed to underlying tissue, atypical location (e.g. [[supraclavicular]] node), associated risk factors (e.g. [[HIV]] or [[TB]]), [[fever]], and/or weight loss, and [[splenomegaly]]. On the other hand, diagnostic criteria for benign [[lymphadenopathy]] may include: node smaller than 1 cm, a node that is mobile, soft-or tender, and is not fixed to underlying tissue, typical location (e.g. [[supraclavicular]] node), no associated risk factors, and palpable and painful enlargement. | Diagnostic criteria could help to differentiate lymphadenopathy causes. Diagnostic criteria for malignant [[lymphadenopathy]] may include: the size of [[node]] more than 2 cm, a node that is draining, hard, or fixed to underlying tissue, atypical location (e.g. [[supraclavicular]] node), associated risk factors (e.g. [[HIV]] or [[TB]]), [[fever]], and/or weight loss, and [[splenomegaly]]. On the other hand, diagnostic criteria for benign [[lymphadenopathy]] may include: node smaller than 1 cm, a node that is mobile, soft-or tender, and is not fixed to underlying tissue, typical location (e.g. [[supraclavicular]] node), no associated risk factors, and palpable and painful enlargement. | ||
==Diagnostic Criteria== | ==Diagnostic Criteria== | ||
Revision as of 18:29, 14 May 2021
|
Lymphadenopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphadenopathy diagnostic criteria On the Web |
|
American Roentgen Ray Society Images of Lymphadenopathy diagnostic criteria |
|
Risk calculators and risk factors for Lymphadenopathy diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]Delband Yekta Moazami, M.D.[3]
Overview
Diagnostic criteria could help to differentiate lymphadenopathy causes. Diagnostic criteria for malignant lymphadenopathy may include: the size of node more than 2 cm, a node that is draining, hard, or fixed to underlying tissue, atypical location (e.g. supraclavicular node), associated risk factors (e.g. HIV or TB), fever, and/or weight loss, and splenomegaly. On the other hand, diagnostic criteria for benign lymphadenopathy may include: node smaller than 1 cm, a node that is mobile, soft-or tender, and is not fixed to underlying tissue, typical location (e.g. supraclavicular node), no associated risk factors, and palpable and painful enlargement.
Diagnostic Criteria
Diagnostic criteria could help to differentiate lymphadenopathy causes.[1][2]
Malignant Lymphadenopathy
- Node > 2 cm
- Node that is draining, hard, or fixed to underlying tissue
- Atypical location (e.g. supraclavicular node)
- Risk factors (e.g. HIV or TB)
- Fever and/or weight loss
- Splenomegaly
Benign Lymphadenopathy
- Node < 1 cm
- Node that is mobile, soft-or tender, and is not fixed to underlying tissue
- Common location (e.g. supraclavicular node)
- No associated risk factors
- Palpable and painful enlargement
References
- ↑ Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A (2014). "Peripheral lymphadenopathy: approach and diagnostic tools". Iran J Med Sci. 39 (2 Suppl): 158–70. PMC 3993046. PMID 24753638.
- ↑ Ferrer R (October 1998). "Lymphadenopathy: differential diagnosis and evaluation". Am Fam Physician. 58 (6): 1313–20. PMID 9803196.